Streamlined In Vitro Transcription for Generating Self‐Amplifying RNA With Modified Nucleotides
Current Protocols · 2026-06 · 6 (6)
DOI: 10.1002/cpz1.70406 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Protocols, online erschienen am 19.06.2026. Verfasst von Harish Prakash und 2 weiteren Autor:innen. Beteiligte Einrichtung: Tata Institute for Genetics and Society, Bengaluru, India. Hauptthemen laut MEDLINE: Transcription, Genetic, RNA, Viral, Nucleotides. Die Arbeit nennt 12 Literaturangaben. Gefördert von: TATA TRUSTS, DST-INSPIRE Faculty Fellowship.
Abstract (Originalsprache)
Self‐amplifying RNA (saRNA) derived from alphavirus replicons enables robust intracellular RNA amplification and high‐level protein expression at substantially lower doses than nonreplicating messenger RNA (mRNA) platforms. Venezuelan equine encephalitis virus (VEEV)‐based replicons lacking the viral structural genes are among the most extensively characterized saRNA backbones, combining efficient cytoplasmic replication with a favorable safety profile. However, incorporating chemical nucleoside modifications such as N1‐methylpseudouridine (m 1 ψ), now standard in conventional mRNA workflows, can directly impact replicase activity and hinder RNA amplification, necessitating backbone‐specific optimization. Recent studies have shown that incorporation of 5‐methylcytidine (m 5 C) preserves VEEV saRNA replication while reducing innate immune activation and improving expression durability. In an independent study, phosphatase treatment to remove residual 5′‐triphosphates was shown to enhance saRNA functionality. Building on these findings, here we describe a streamlined protocol for generating m 5 C‐modified VEEV‐based saRNA using a single‐step in vitro transcription (IVT) strategy. This protocol utilizes PCR‐generated DNA templates with an encoded poly(A) tail, CleanCap AU for co‐transcriptional capping, and post‐transcriptional phosphatase treatment to minimize immunostimulatory RNA species. Finally, the RNA was purified using the phenol‐chloroform‐isoamyl alcohol method and functionally evaluated by transfection into HEK293T cells. This protocol provides a reproducible framework for producing capped, tailed, and chemically modified saRNA suitable for downstream functional and translational studies. © 2026 Wiley Periodicals LLC. Basic Protocol 1 : IVT and purification of saRNA with modified nucleotides Basic Protocol 2 : Functional assessment of IVT–generated saRNA in HEK293T Cells
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tata Institute for Genetics and Society, Bengaluru, India.
- These authors contributed equally to this work.
- Academy of Scientific and Innovative Research, Ghaziabad, India.
ORCID-Profile: Vasanth Thamodaran
Förderung
- TATA TRUSTS
- DST-INSPIRE Faculty Fellowship
Zitieren
APA
Prakash, H., Velu, K. K., & Thamodaran, V. (2026). Streamlined In Vitro Transcription for Generating Self‐Amplifying RNA With Modified Nucleotides. Current Protocols, 6(6). https://doi.org/10.1002/cpz1.70406
Vancouver
Prakash H, Velu KK, Thamodaran V. Streamlined In Vitro Transcription for Generating Self‐Amplifying RNA With Modified Nucleotides. Current Protocols. 2026;6(6). doi:10.1002/cpz1.70406
BibTeX
@article{Prakash2026,
author = {Prakash, Harish and Velu, Karthik Kadhir and Thamodaran, Vasanth},
title = {Streamlined In Vitro Transcription for Generating Self‐Amplifying RNA With Modified Nucleotides},
journal = {Current Protocols},
year = {2026},
volume = {6},
number = {6},
doi = {10.1002/cpz1.70406}
}
EUVIMED